AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Neurogene Inc. Director's Dealing 2016

Jun 15, 2016

33497_dirs_2016-06-15_34b4f3da-05a2-445e-ad7d-ba21827d8cca.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2016-06-06

Reporting Person: Jenkins Abigail (Chief Commercial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct